Hereditary elliptocytosis
MONDO:0017319Hereditary elliptocytosis (HE) is a rare clinically and genetically heterogeneous disorder of the red cell membrane characterized by manifestations ranging from mild to severe transfusion-dependent hemolytic anemia but with the majority of patients being asymptomatic.
Also known as: HE, Hashimoto Encephalopathy, congenital elliptocytosis, hereditary ovalocytosis, ovalocytosis
11 clinical trials for this condition and its sub-types, 0 tagged with Hereditary elliptocytosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hereditary elliptocytosis
-
Southeast Asian ovalocytosis 2 trials
-
Elliptocytosis 1 0 trials
-
Elliptocytosis 2 0 trials
-
Elliptocytosis 3 0 trials
-
Could an Iron-Removing pill protect the brain after a burst aneurysm?
Disease control OngoingThis study tests whether the drug deferiprone can safely lower iron levels in the brain after a bleeding aneurysm. About 66 adults who had a ruptured aneurysm will receive either deferiprone or a placebo for 14 days. Researchers will measure iron in spinal fluid, brain MRI scans,…
Phase 1/2 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New blood treatment could block zika in transfusions
Disease control OngoingThis study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…
Phase 3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC